论文部分内容阅读
目的探讨门冬胰岛素30注射液与阿卡波糖的联合降糖效果。方法 80例糖尿病患者随机分为研究组(40例)和对照组(40例)。对照组患者采取门冬胰岛素30治疗方案,研究组患者在对照组基础上给予门冬胰岛素30注射液与阿卡波糖联合治疗,对两组患者临床降糖效果进行观察评定。结果研究组患者经治疗后,其患者临床血糖含量得到明显改善,降糖效果明显,显著优于对照组(P<0.05)。结论在临床中,应用门冬胰岛素30注射液与阿卡波糖的联合降糖,可以提高患者在临床治疗效果,有效降低患者并发症的发生,提高疾病治愈率。
Objective To investigate the combined hypoglycemic effect of insulin aspart 30 and acarbose. Methods Eighty diabetic patients were randomly divided into study group (40 cases) and control group (40 cases). Patients in the control group were treated with insulin aspart 30. Patients in the study group were given insulin aspart 30 injection combined with acarbose on the basis of the control group, and clinical hypoglycemic effect was observed and evaluated in both groups. Results The study group patients after treatment, the clinical blood glucose levels were significantly improved, hypoglycemic effect was significantly better than the control group (P <0.05). Conclusion In clinic, the application of insulin aspart 30 injection combined with acarbose hypoglycemic can improve the clinical efficacy of patients, effectively reduce the incidence of complications and improve the cure rate of the disease.